Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other biologically active compounds. Its structure allows for selective modification in drug design, making it valuable in creating agents targeting inflammation, cancer, and central nervous system disorders. The tert-butyl carbamate (Boc) group provides stability during synthesis and enables controlled deprotection for further functionalization. The chloropyrazole moiety contributes to binding affinity in various enzymatic assays, enhancing its utility in medicinal chemistry research.